In BREAKWATER, EC plus FOLFIRI achieved a 64.4% response rate and showed a trend toward improved overall survival in patients ...

Dr. Ian Flinn, chief scientific officer at Tennessee Oncology and One Oncology in Nashville, Tennessee, explains Lunsumio ...

Oya Gilbert blends hip-hop and advocacy to raise awareness about myeloma, engage patients, and address broader health issues ...

Donna Rigby, a grandmother living in Asbury Park, New Jersey and a former licensed practical nurse (LPN), experienced a ...

Joe McDonough, president of The Andrew McDonough B+ (Be Positive) Foundation, has spent nearly 20 years supporting children ...

Treatment for stage 3 myeloma is typically divided into phases. The goal is to achieve a deep remission, meaning the cancer is undetectable. This is the first phase. Most patients receive a "triplet" ...

The FDA accepted Besremi's application for essential thrombocythemia, supported by SURPASS-ET and EXCEED-ET trial results, with a review target date of August 30, 2026. Essential thrombocythemia is a ...

Survival is not a victory parade; it is a long-term contract with chronic illness.

Hair loss during cancer treatment can feel like a loss of control, impacting identity and self-expression. Choosing to shave ...

Tukysa (tucatinib) may represent a new patient-friendly option as a first line maintenance treatment possibility for patients ...

Staying physically active, especially through regular walking, may help reduce cancer-related fatigue and improve quality of ...

Patients share their experiences on the importance of seeking second opinions and expert care in managing complex myeloma ...